Company
Sun Pharmaceutical
Sun Pharmaceutical Industries Limited manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in over 100 countries.
Sun Pharmaceutical is a publicly traded company operating in the pharmaceutical industry sector, based in India. It trades on the Bombay Stock Exchange under the ticker 524715. Leadership tracked by CEOInsider includes Dilip Shanghvi (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Sun Pharmaceutical's major acquisition of Organon for approximately $11.75 billion, which is expected to be completed by the fourth quarter and positions the company as a significant global player in the pharmaceutical industry. The deal has received substantial media attention as a transformative move for the Indian pharmaceutical sector, with founder Dilip Shanghvi acknowledging both the opportunity and financial challenges involved. Additionally, Shanghvi has been recognized with multiple industry leadership awards, while the company has emphasized its commitment to developing products that will serve global patients.
Summarized from the headlines in the sidebar; see each source for the full story.